Literature DB >> 9853867

Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium.

M T Comer1, H J Leese, J Southgate.   

Abstract

Human Fallopian tubal epithelial cells in culture lose morphological features associated with the epithelium in situ and the extent to which they retain their in-vivo phenotype or function is unknown. In order to address this question, immunocytochemical markers were identified which distinguish secretory (HMFG2+, LhS28-) from ciliated (HMFG2-, LhS28+) epithelial cells in tissue sections of Fallopian tube. These markers were used to analyse the phenotype of tubal cells in vitro. Primary cultures of human tubal epithelial cells were seeded onto glass and grown to confluence before addition of oestradiol-17beta. In the absence of hormone, tubal epithelial cells expressed cytokeratins and nuclear receptors for oestrogen and progesterone and adopted a homogeneous (HMFG2+, LhS28-) secretory cell phenotype. Following the addition of oestradiol-17beta, a proportion of cells became positive for LhS28. The induction of a ciliated epithelial cell phenotype was confirmed by scanning electron microscopy, where on permeable collagen membranes, approximately one-third of tubal epithelial cells became ciliated in the presence of oestradiol-17beta. We suggest that in vitro, tubal epithelial cells adopt an immature secretory-like phenotype and that oestrogen can induce differentiation to a ciliated epithelial cell phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853867     DOI: 10.1093/humrep/13.11.3114

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  24 in total

Review 1.  Estrogen, efferent ductules, and the epididymis.

Authors:  Avenel Joseph; Barry D Shur; Rex A Hess
Journal:  Biol Reprod       Date:  2010-10-06       Impact factor: 4.285

2.  Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.

Authors:  Eleanor Y Chen; Karishma Mehra; Mitra Mehrad; Gang Ning; Alexander Miron; George L Mutter; Nicholas Monte; Bradley J Quade; Frank D McKeon; Yosuf Yassin; Wa Xian; Christopher P Crum
Journal:  J Pathol       Date:  2010-09       Impact factor: 7.996

3.  Sex hormone-dependent regulation of cilia beat frequency in airway epithelium.

Authors:  Raksha Jain; Jennifer M Ray; Jie-hong Pan; Steven L Brody
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-27       Impact factor: 6.914

4.  The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.

Authors:  Hiroshi Kobayashi; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada; Kenji Ogawa; Naoki Kawahara
Journal:  Biomed Rep       Date:  2017-07-27

5.  Fallopian tube correlates of ovarian serous borderline tumors.

Authors:  Anna R Laury; Gang Ning; Charles M Quick; Jonathan Bijron; Mana M Parast; Rebeca A Betensky; Sara O Vargas; Frank D McKeon; Wa Xian; Marisa R Nucci; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

6.  Application of a marker of ciliated epithelial cells to gynaecological pathology.

Authors:  M T Comer; A C Andrew; H J Leese; L K Trejdosiewicz; J Southgate
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

Review 7.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

8.  Ovarian cancer pathogenesis: a model in evolution.

Authors:  Alison M Karst; Ronny Drapkin
Journal:  J Oncol       Date:  2009-09-06       Impact factor: 4.375

9.  [Serous genital carcinoma: molecular pathogenesis and the role of tubal fimbria].

Authors:  S Lax
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

10.  Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.

Authors:  K Levanon; V Ng; H Y Piao; Yi Zhang; M C Chang; M H Roh; D W Kindelberger; M S Hirsch; C P Crum; J A Marto; R Drapkin
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.